---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-030491"
form_type: "8-K"
ticker: "AMRX"
cik: "0001723128"
company_name: "Amneal Pharmaceuticals, Inc."
filed_at: "2026-07-31T20:08:50+00:00"
generated_at: "2026-07-31T20:10:16.644687+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Amneal shareholders approve acquisition of Kashiv BioSciences; closing expected H2 2026

## Summary
- Stockholders approved Purchase Agreement to acquire 100% of Kashiv BioSciences membership interests.
- Approved issuance of 28,942,108 shares of Class A common stock to Sellers in connection with the deal.
- Vote results: Transaction Proposal 138,265,079 for, 655,759 against, 67,147 abstain; Stock Issuance Proposal 286,714,072 for, 1,791,016 against, 62,071 abstain.
- Closing expected in second half of 2026, subject to remaining conditions.

## SEC filing metadata
- accession: 0001140361-26-030491
- form_type: 8-K
- ticker: AMRX
- cik: 0001723128
- company_name: Amneal Pharmaceuticals, Inc.
- filed_at: 2026-07-31T20:08:50+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1723128/000114036126030491/0001140361-26-030491-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1723128/000114036126030491/ef20079129_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-030491
- JSON: https://secwatch.observer/filing/0001140361-26-030491.json
- Plain text: https://secwatch.observer/filing/0001140361-26-030491.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.